The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration --improving the quality of cardiovascular care in the Asia Pacific region.
BACKGROUND
Clinicians and other stakeholders recognize the need for clinical registries to monitor data in order to improve the outcome and quality of care in the delivery of medical interventions. The establishment of a collaboration across the Asia Pacific Region to inform on variations in patient and procedural characteristics and associated clinical outcomes would enable regional benchmarking of quality.


OBJECTIVE
The aims of the collaboration are a) to identify the characteristics of patients undergoing PCI across the Asia Pacific region, b) to report on outcomes of patients undergoing PCI, c) to develop an appropriate ethnic and region specific risk adjustment model for patients undergoing PCI and d) to establish a registry framework for research, education and training in the area of cardiovascular interventions across the Asia Pacific Region. Descriptive characteristics of patient undergoing PCI over a 12 month period were collated and reported.


RESULTS
Representatives from 27 hospitals attended the inaugural meeting with interested parties from Australia, Singapore, Malaysia and Hong Kong. In every country, males predominated PCI activity. Subjects were older and had higher rates of family history of cardiovascular disease in Australia, while Asian subjects had higher rates of diabetes, dyslipidemia and renal failure. STEMI presentation was higher in Australia than in Asia and drug eluting stent use was higher in Asia. Procedural success rates were similar across the region (>95%).


CONCLUSIONS
Procedural success was similar across the region despite differing patient characteristics across countries in terms of pre-procedural risk factors and clinical presentation.
CCRE Therapeutics, Monash University, Melbourne, Vic, Australia; Melbourne Interventional Group, Vic, Australia. Electronic address: chris.reid@monash.edu.
Christopher M
CM
Reid
Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Bryan
B
Yan
National Cardiovascular Disease Database Registry of Malaysia, Malaysia; Department of Medicine, University of Malaysia, Malaysia.
Wan Azman
WA
Wan Ahmad
Department of Medicine, University of Malaysia, Malaysia; Department of Cardiology, Sarawak General Hospital, Faculty of Medicine, University of Malaysia, Sarawak, Malaysia.
Liew Houng
LH
Bang
National Cardiovascular Disease Database Registry of Malaysia, Malaysia; Department of Medicine, University of Malaysia, Malaysia.
Sim Kui
SK
Hian
National Heart Centre, Singapore.
Terrance
T
Chua
National University Heart Centre, Singapore.
Mark
M
Chan
Coronary Angiography Registry Database of South Australia (CARDOSA) registries, SA, Australia; Department of Medicine, University of Adelaide, SA, Australia.
John
J
Beltrame
CCRE Therapeutics, Monash University, Melbourne, Vic, Australia.
Stephen J
SJ
Duffy
CCRE Therapeutics, Monash University, Melbourne, Vic, Australia; Melbourne Interventional Group, Vic, Australia.
Angela
A
Brennan
Melbourne Interventional Group, Vic, Australia; Coronary Care Unit, Royal Melbourne Hospital, Vic, Australia.
Andrew
A
Ajani
D000368:Aged; D044466:Asian People; D001315:Australia; D019985:Benchmarking; D002318:Cardiovascular Diseases / Q000208:ethnology* / Q000628:therapy*; D003299:Cooperative Behavior; D003906:Developing Countries; D005260:Female; D006723:Hong Kong; D006801:Humans; D008296:Malaysia; D008297:Male; D008875:Middle Aged; D058996:Quality Improvement; D012042:Registries / Q000592:standards*; D012307:Risk Factors; D012846:Singapore; D044465:White People
Patient outcomes; Percutaneous coronary interventions; Registries